Authors:
Pinto, CG
Lafuma, A
Fagnani, F
Nuijten, MJC
Berdeaux, G
Citation: Cg. Pinto et al., Cost effectiveness of emedastine versus levocabastine in the treatment of allergic conjunctivitis in 7 European countries, PHARMACOECO, 19(3), 2001, pp. 255-265
Citation: C. Le Pen et G. Berdeaux, Diagnosis related group costs in a regulated environment - A note about their economic interpretation, PHARMACOECO, 17(2), 2000, pp. 115-120
Authors:
Rouillon, F
Berdeaux, G
Bisserbe, JC
Warner, B
Mesbah, M
Smadja, C
Chwalow, J
Citation: F. Rouillon et al., Prevention of recurrent depressive episodes with milnacipran: consequenceson quality of life, J AFFECT D, 58(3), 2000, pp. 171-180
Citation: Jp. Martin et al., Epidemiology and economics of chemotherapy combinations in the treatment of advanced breast cancer, THERAPIE, 55(1), 2000, pp. 127-131
Authors:
Dardennes, R
Berdeaux, G
Lafuma, A
Fagnani, F
Citation: R. Dardennes et al., Comparison of the cost-effectiveness of milnacipran (a SNRI) with TCAs andSSRIs: a modeling approach, EUR PSYCHIA, 14(3), 1999, pp. 152-162
Authors:
van Cauwenberge, P
Berdeaux, G
Morineau, A
Smadja, C
Allaire, JM
Citation: P. Van Cauwenberge et al., Use of diagnostic clusters to assess the economic consequences of rhinopharyngitis in children in Italy and France during the winter, CLIN THER, 21(2), 1999, pp. 404-421